Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single-arm,Exploratory Clinical Study of Albumin-bound Paclitaxel Combination With Dalpiciclib and AI in the Treatment of ER-Low (1%-10%), HER2-negative Advanced Breast Cancer

NCT06711094 is registered in ClinicalTrials.gov with Fujian Medical University as lead sponsor.

NCT NCT06711094
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06711094 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single-arm,Exploratory Clinical Study of Albumin-bound Paclitaxel Combination With Dalpiciclib and AI in the Treatment of ER-Low (1%-10%), HER2-negative Advanced Breast Cancer
Lead sponsor
Fujian Medical University
Phase
Not applicable
Overall status
Not yet recruiting
Start date
January 1, 2025
Completion date
December 30, 2028
Enrollment
52 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hr+/her2- advanced breast cancer